Niacinamide for acne-prone skin: calm, clear, and (mostly) drama-free

What is niacinamide?

Niacinamide is a water-soluble form of vitamin B3. It is one of the most researched cosmetic actives available, with a broad body of published evidence supporting its use in acne-prone, oily and sensitive skin.

Unlike some actives that do one thing well, niacinamide works across several skin concerns at once: it helps calm the appearance of inflammation, supports the skin barrier, reduces the look of post-blemish marks, and is generally well tolerated, even alongside other actives (Gehring, 2004).

Found in Upenya’s Moisturising Gel, niacinamide sits at the centre of a straightforward three-step routine designed to support acne-prone skin at every age.

What niacinamide does for acne-prone skin

Helps keep blemishes in check

A well-designed clinical trial found that 4% niacinamide gel performed comparably to 1% clindamycin gel - a prescription topical antibiotic - in reducing inflammatory lesions in moderate acne (Shalita et al., 1995). Importantly, niacinamide achieves this without contributing to antibiotic resistance, which is a growing concern with long-term antibiotic use in acne management (Shalita et al., 1995).

Strengthens the skin barrier

Niacinamide stimulates the production of ceramides and other barrier lipids within the skin. This is linked to reduced transepidermal water loss and improved skin comfort — particularly relevant for acne-prone skin that can swing between oily and dehydrated (Tanno et al., 2000; Gehring, 2004).

A stronger barrier also means the skin is better positioned to tolerate other active ingredients in a routine.

Helps fade the appearance of post-blemish marks

Post-inflammatory hyperpigmentation (PIH) - the dark marks left behind after spots - is a common concern for acne-prone skin. Niacinamide reduces melanosome transfer, the process by which pigment is passed from melanocytes to surrounding skin cells. In clinical studies, this translated into a measurable improvement in skin tone evenness over time (Hakozaki et al., 2002).

Reduces redness and uneven texture

Clinical work with 5% niacinamide demonstrated improvements in skin redness, blotchiness and surface texture, with good tolerability reported even in subjects with sensitive skin (Bissett, Oblong and Berge, 2005). These properties make it a practical choice for skin that tends to react easily.

The science in plain language

How it behaves

Niacinamide is non-acidic and water-soluble, which means it integrates well into moisturisers and sits comfortably alongside SPF and other daily skincare steps (Gehring, 2004).

What concentration to look for

Most published studies supporting the benefits above used concentrations between 2% and 5% for daily leave-on application. Higher concentrations are not necessarily more effective and may cause sensitivity in some skin types (Shalita et al., 1995; Bissett, Oblong and Berge, 2005).

Who it is suited to

Niacinamide is particularly well suited to oily, combination and acne-prone skin. It also works as a supportive layer alongside more targeted actives, helping the skin stay balanced while other ingredients do their work (Gehring, 2004).

A simple routine built around niacinamide

Upenya’s Exfoliating Cleanser, Moisturising Gel and Blemish Care are designed to work together. Niacinamide in the Moisturising Gel acts as the balancing midpoint between a gentle cleanse and targeted blemish support.

Morning routine

Cleanse:

Upenya Exfoliating Cleanser - a gentle, microbiome-friendly cleanse to remove overnight build-up without stripping the skin.

Balance and support:

Upenya Moisturising Gel - niacinamide supports the barrier and maintains skin comfort throughout the day (Tanno et al., 2000; Gehring, 2004).

Target:

Upenya Blemish Care - apply to active spots and breakout-prone areas to calm the appearance of inflammation and help manage excess oil.

Protect:

Broad-spectrum SPF applied every morning. Consistent sun protection also helps prevent existing post-blemish marks from deepening.

Evening routine

Cleanse:

Upenya Exfoliating Cleanser - remove the day’s build-up before actives are applied.

Soothe and support:

Upenya Moisturising Gel - supports barrier recovery overnight.

Target:

Upenya Blemish Care - apply a thin layer to breakout-prone areas and allow to dry.

Practical guidance

• Introduce niacinamide once daily for the first week, then move to morning and evening once your skin has adjusted.

• Add new routine steps one at a time. This makes it easier to identify how your skin is responding.

• Allow 8 to 12 weeks for visible improvements. Consistent daily use is more important than frequency of application (Shalita et al., 1995; Hakozaki et al., 2002).

  
  

Frequently asked questions

Will niacinamide dry out my skin?

No. Niacinamide supports the production of barrier lipids and helps the skin retain moisture. It is one of the few actives that addresses oiliness and dehydration at the same time (Tanno et al., 2000).

Does niacinamide replace targeted acne care?

No single ingredient addresses all aspects of acne. Niacinamide in Upenya’s Moisturising Gel is the foundation layer — it keeps the skin balanced and comfortable while targeted steps such as Upenya Blemish Care address active breakouts. Each product plays a distinct role, and the routine works best when used consistently as a whole (Gehring, 2004).

Is niacinamide suitable for sensitive skin?

Generally, yes. It is among the better-tolerated cosmetic actives, with good tolerability reported even in sensitive skin (Bissett, Oblong and Berge, 2005). As with any new product, a patch test is recommended before full use.

When should I consult a professional?

If blemishes or acne persist despite a consistent, well-structured routine, it is advisable to consult a dermatologist or medically trained professional for assessment and guidance on medical-grade treatment options.

Summary

Niacinamide is a well-evidenced cosmetic active with demonstrated benefits for acne-prone skin: it calms the appearance of inflammation, strengthens the skin barrier, reduces the look of post-blemish marks, and supports an even skin tone. Present in Upenya’s Moisturising Gel, it forms the core of a twice-daily routine that is straightforward to follow and grounded in published scientific evidence (Shalita et al., 1995; Gehring, 2004; Tanno et al., 2000; Hakozaki et al., 2002; Bissett, Oblong and Berge, 2005).

Regulatory note: This blog uses cosmetic language consistent with cosmetic regulations, referring to the appearance, comfort and support of healthy-looking skin. For persistent or severe acne, consult a healthcare professional. Patch test new products before full use and discontinue if irritation occurs.

References

Bissett, D.L., Oblong, J.E. and Berge, C.A. (2005) ‘Niacinamide: a B vitamin that improves aging facial skin appearance’, Dermatologic Surgery, 31(7 Pt 2), pp. 860–866. Available at: https://doi.org/10.1111/j.1524-4725.2005.31732 (Accessed: 11 June 2026).

Gehring, W. (2004) ‘Nicotinic acid/niacinamide and the skin’, Journal of Cosmetic Dermatology, 3(2), pp. 88–93. Available at: https://doi.org/10.1111/j.1473-2130.2004.00115.x (Accessed: 11 June 2026).

Hakozaki, T., Minwalla, L., Zhuang, J., Chhoa, M., Matsubara, A., Miyamoto, K., Greatens, A., Hillebrand, G.G., Bissett, D.L. and Boissy, R.E. (2002) ‘The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer’, British Journal of Dermatology, 147(1), pp. 20–31. Available at: https://doi.org/10.1046/j.1365-2133.2002.04834.x (Accessed: 11 June 2026).

Shalita, A.R., Smith, J.G., Parish, L.C., Sofman, M.S. and Chalker, D.K. (1995) ‘Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris’, International Journal of Dermatology, 34(6), pp. 434–437. Available at: https://doi.org/10.1111/j.1365-4362.1995.tb04449.x (Accessed: 11 June 2026).

Tanno, O., Ota, Y., Kitamura, N., Katsube, T. and Inoue, S. (2000) ‘Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier’, British Journal of Dermatology, 143(3), pp. 524–531. Available at: https://doi.org/10.1111/j.1365-2133.2000.03705.x (Accessed: 11 June 2026).